Cancer risks in radiotherapy workflow
What is it about?
The exact mechanism and dose–response relationship for radiation-induced malignancy are not well understood. In this review, we develop risk assessments based on our current knowledge of IGRT and provide strategies for cancer risk reduction.
Why is it important?
Modern risk-based analysis shows that many errors that occur in radiation oncology are due to failures in workflow. These errors can lead to imbalance between benefits and risks.
The following have contributed to this page: Fu Jin
In partnership with: